Combination Targeted Therapy with Lenvatinib and Pembrolizumab in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers

Zhou M, Velez LM, Kwan D, Moses L, Johnson CD, Nguyen CM, Mott L, Gamie F, Fouladi M, Bae H, Verlande A, Arneson D, Petrus[...]

Cleveland S, Carroll JE, Montoya AK, Cha L, Stiles L, Sumner JA. Early Life Adversity and Mitochondrial Function: Comparing Cumulative Risk and Dimensional Models of[...]

Clair K, Fletcher EH, Oishi A, Schweizer CA, Jackson L, Chanfreau C, Finley EP, Hamilton A, Moin T, Farmer MM, Bean-Mayberry B. "It's Just a[...]